South Korea-based International Vaccine Institute (IVI) and the Government of Brazil have taken an important step toward establishing the Bridging Research Investment in Global Health Technology (BRIGHT) Fund.
IVI and Brazil signed letters of intent supporting the establishment of the BRIGHT Fund, a multi-donor, country-led financing platform designed to accelerate health innovation and expand equitable access to life-saving technologies.
The BRIGHT Fund is a multi-donor financing platform under development aimed at addressing persistent gaps in global health innovation. Despite growing scientific capacity in low- and middle-income countries, many promising innovations fail to reach populations and deliver health impact due to insufficient and fragmented financing and limited end-to-end development partnerships. The BRIGHT Fund seeks to bridge this “valley of death” by providing sustained, milestone-based investment in the Global South to support the full pathway from research to commercialization and local production, while also fostering the growth of small- and medium-sized enterprises and supporting job creation and broader economic development.
With a target of mobilising $300 million over its first five years, the BRIGHT Fund is expected to support the development and production of vaccines, therapeutics, diagnostics, and digital health innovations.
